Prostate Cancer: Early Detection Leads to Better Outcomes
10/9/2025
Dr. Thomas Oliver, Aspirus Oncologist and Hematologist
About one in eight men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. While it is one of the most common cancers in men, early detection remains one of the most effective ways to improve outcomes.
“Prostate cancer is a very broad disease in terms of how aggressive it can be and the type of treatment it may require,” said Thomas Oliver, DO, Oncologist and Hematologist with Aspirus Health. “Some patients can be safely monitored throughout their lives and never need treatment, while others may need more advanced therapies such as chemotherapy or radiation.”
Prostate cancer is often driven by male hormones called androgens, including testosterone, that can fuel its growth. Treatments are designed to lower or block these hormones to stop the disease from spreading. In many cases, treatment involves injections, oral medications, or a combination of both.
“Radiation also plays a significant role,” Dr. Oliver explained. “It can be used on its own or alongside hormone-lowering therapy. In some cases, surgery may also be recommended to remove the prostate.”
Routine screening is the most effective way to identify prostate cancer before symptoms appear. The PSA test can help detect early signs of cancer when it is most curable and treatable.
Recent national data reinforce that importance. A study published in CA: A Cancer Journal for Clinicians (September 2025) found that prostate cancer incidence in the United States is rising again, up about three percent per year since 2014, with more men being diagnosed at advanced stages. These findings underscore why regular check-ups and timely PSA discussions remain critical.
“It’s a simple blood test that can make a huge difference,” Dr. Oliver said. “A quick screening today could mean avoiding advanced disease down the road.”
While screening recommendations vary, most men should begin discussions about prostate cancer testing between ages 50 and 55. Those with higher risk, such as a family history of prostate cancer, may need to start earlier.
“The key is prevention,” Dr. Oliver emphasized. “Having a trusted primary care provider and staying current with recommended screenings can make all the difference.”
Schedule your annual check-up and make prostate health part of the conversation. Visit aspirus.org to learn more or find a provider near you.
Back to all Posts